However, more in vivo and in vitro experiments are required to illuminate the specific functions of DAPK2 in immunoregulation disorder, metabolism abnormalities, corpus luteum dysfunction and miscarriage of PCOS, reinforcing the theoretical foundation of target therapy for promoting the PCOS prognosis. The gene discussed is DAPK2; the disease is polycystic ovary syndrome.